Increased device thresholds with subsequent improvement status post-systemic therapy in a patient with multiple myeloma
- PMID: 34820265
- PMCID: PMC8602117
- DOI: 10.1016/j.hrcr.2021.05.005
Increased device thresholds with subsequent improvement status post-systemic therapy in a patient with multiple myeloma
Keywords: Cardiac amyloidosis; Chemotherapy; Device failure; Increasing device thresholds; Multiple myeloma.
Figures
References
-
- Mulpuru S.K., Madhavan M., McLeod C.J., Cha Y.M., Friedman P.A. Cardiac pacemakers: function, troubleshooting, and management: part 1 of a 2-part series. J Am Coll Cardiol. 2017;69:189–210. - PubMed
-
- Dohrmmann M.L., Goldschlager N.F. Myocardial stimulation threshold in patients with cardiac pacemakers: effects of physiologic variables, pharmacologic agents, and lead electrodes. Cardiol Clin. 1985;3:527–537. - PubMed
-
- Maisel W.H., Hauser R.G., Hammill S.C., et al. Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA) Heart Rhythm. 2009;6:869–885. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
